Anna Sanigorska

Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Treated With Recombinant von Willebrand Factor in Surgical Settings in the United Kingdom

Heena Howitt, Cheryl Jones, Sarah Brighton, Rosa Willock et autres

OBJECTIVES: We describe treatment outcomes and healthcare resource utilisation (HCRU) in adults with von Willebrand disease (VWD) receiving recombinant von Willebrand factor (rVWF) in surgical settings in the United Kingdom. METHODS: Retrospective chart review of adults (≥ 18 years) with congenital VWD …

gb (code pays fourni par la source)

Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Receiving On‐Demand Recombinant von Willebrand Factor in the United Kingdom

Heena Howitt, Cheryl Jones, Sarah Brighton, Rosa Willock et autres

OBJECTIVES: We describe treatment outcomes and healthcare resource utilisation (HCRU) in adults with von Willebrand disease (VWD) treated on demand with recombinant von Willebrand factor (rVWF) in the United Kingdom. METHODS: Retrospective chart review of adults (≥ 18 years) with congenital VWD …

gb (code pays fourni par la source)

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy, Merrole Cole‐Sinclair et autres

The lived experience of women with a bleeding disorder: A systematic review

Anna Sanigorska, Steve Chaplin, Michael Holland, Kate Khair et autres

BACKGROUND: Research studies have described the morbidity associated with inherited bleeding disorders such as hemophilia and von Willebrand disease in women, but their effect on daily living has long been underrecognized. This systematic review sought to document the lived experience of women …

gb (code pays fourni par la source)

Haemophilia specialist nurses’ perceptions of haemophilia B

Steve Chaplin, Maj Friberg Birkedal, Erica Crilly, Simon Fletcher et autres

Abstract Introduction Some clinicians believe that haemophilia B is associated with less bleeding than haemophilia A, yet there appears to be little difference in health-related outcomes. Current clinical practice reduces the risk of bleeds, making differences difficult to measure. We surveyed specialist …

se, gb, dk, nl, ca, es (code pays fourni par la source)